Hypercoagulability in β-thalassemia

A status quo

Maria Domenica Cappellini, Erika Poggiali, Ali T. Taher, Khaled M. Musallam

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Life expectancy of thalassemia patients has markedly improved over the last few decades, but patients still suffer from many complications of their congenital chronic disease, and several new complications are now being acknowledged, including thrombosis. The high prevalence of thromboembolic events, especially in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. This review summarizes current knowledge of the clinical and pathophysiological characteristics of hypercoagulability in thalassemia patients. Strategies to prevent thrombotic events are also discussed.

Original languageEnglish
Pages (from-to)505-512
Number of pages8
JournalExpert Review of Hematology
Volume5
Issue number5
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Thalassemia
Thrombophilia
beta-Thalassemia
Life Expectancy
Thrombosis
Chronic Disease

Keywords

  • coagulopathy
  • hypercoagulability
  • thalassemia intermedia
  • thalassemia major
  • thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Hypercoagulability in β-thalassemia : A status quo. / Cappellini, Maria Domenica; Poggiali, Erika; Taher, Ali T.; Musallam, Khaled M.

In: Expert Review of Hematology, Vol. 5, No. 5, 10.2012, p. 505-512.

Research output: Contribution to journalArticle

Cappellini, Maria Domenica ; Poggiali, Erika ; Taher, Ali T. ; Musallam, Khaled M. / Hypercoagulability in β-thalassemia : A status quo. In: Expert Review of Hematology. 2012 ; Vol. 5, No. 5. pp. 505-512.
@article{8c708a78b6b847f79feab3189dace645,
title = "Hypercoagulability in β-thalassemia: A status quo",
abstract = "Life expectancy of thalassemia patients has markedly improved over the last few decades, but patients still suffer from many complications of their congenital chronic disease, and several new complications are now being acknowledged, including thrombosis. The high prevalence of thromboembolic events, especially in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. This review summarizes current knowledge of the clinical and pathophysiological characteristics of hypercoagulability in thalassemia patients. Strategies to prevent thrombotic events are also discussed.",
keywords = "coagulopathy, hypercoagulability, thalassemia intermedia, thalassemia major, thrombosis",
author = "Cappellini, {Maria Domenica} and Erika Poggiali and Taher, {Ali T.} and Musallam, {Khaled M.}",
year = "2012",
month = "10",
doi = "10.1586/ehm.12.42",
language = "English",
volume = "5",
pages = "505--512",
journal = "Expert Review of Hematology",
issn = "1747-4086",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - Hypercoagulability in β-thalassemia

T2 - A status quo

AU - Cappellini, Maria Domenica

AU - Poggiali, Erika

AU - Taher, Ali T.

AU - Musallam, Khaled M.

PY - 2012/10

Y1 - 2012/10

N2 - Life expectancy of thalassemia patients has markedly improved over the last few decades, but patients still suffer from many complications of their congenital chronic disease, and several new complications are now being acknowledged, including thrombosis. The high prevalence of thromboembolic events, especially in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. This review summarizes current knowledge of the clinical and pathophysiological characteristics of hypercoagulability in thalassemia patients. Strategies to prevent thrombotic events are also discussed.

AB - Life expectancy of thalassemia patients has markedly improved over the last few decades, but patients still suffer from many complications of their congenital chronic disease, and several new complications are now being acknowledged, including thrombosis. The high prevalence of thromboembolic events, especially in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. This review summarizes current knowledge of the clinical and pathophysiological characteristics of hypercoagulability in thalassemia patients. Strategies to prevent thrombotic events are also discussed.

KW - coagulopathy

KW - hypercoagulability

KW - thalassemia intermedia

KW - thalassemia major

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84869151495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869151495&partnerID=8YFLogxK

U2 - 10.1586/ehm.12.42

DO - 10.1586/ehm.12.42

M3 - Article

VL - 5

SP - 505

EP - 512

JO - Expert Review of Hematology

JF - Expert Review of Hematology

SN - 1747-4086

IS - 5

ER -